Many of the APPs (ALB, ORM, CRP among others) appear in the routine clinical analysis (by conventional immunoassays) of hospitalized patients and can be applied to stratify COVID-19 patients according to the severity (41). This evidence concerns the gene ORM1 and COVID-19.